Market Overview

UPDATE: BTIG Initiates Rite Aid with PT of $2.25 on Demographic Trends

Share:
Related RAD
Citi: Buy Walgreens' Core, Rite Aid Is A Bonus
Walgreens Boots Alliance Reports Solid Q1, Raises Lower End Of Guidance
January Retail Sales Chilled By Jonas, Stock Market Volatility (Investor's Business Daily)

BTIG initiated coverage on Rite Aid (NYSE: RAD) with a $2.25 price target.

BTIG commented, "Rite Aid operates in a sector that stands to benefit from demographic trends and potentially from legislative undertakings as well. The trends are well-known and easily identifiable: the US population is aging, and the post-Second World War cohort, which is disproportionately large, is moving into the 65+ category. That category, in turn, is an increasingly long-lived customer, an increasingly prescription-intensive customer and an increasingly value-focused customer. Add to this the closing of the “donut hole” in Medicare Part D – a broadly popular policy initiative – and the stage is set for an enduring trend of incremental growth."

Rite Aid closed at $1.14 on Wednesday.

Latest Ratings for RAD

DateFirmActionFromTo
Jan 2016Evercore ISI GroupDowngradesBuyHold
Nov 2015JP MorganDowngradesOverweightNeutral
Oct 2015Credit SuisseDowngradesOutperformNeutral

View More Analyst Ratings for RAD
View the Latest Analyst Ratings

Posted-In: btigAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (RAD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters